BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30232415)

  • 21. Transplantation of related and unrelated umbilical cord blood stem cells in Austria. Austrian Working Party for Stem Cell Transplantation. Austrian Society of Hematology and Oncology.
    Schwinger W; Urban C; Lackner H; Kerbl R; Sovinz P; Gardner H; Peters C; Niederwieser D; Fink FM; Kögler G
    Wien Klin Wochenschr; 1999 May; 111(9):348-53. PubMed ID: 10407995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor.
    Majhail NS; Brunstein CG; Tomblyn M; Thomas AJ; Miller JS; Arora M; Kaufman DS; Burns LJ; Slungaard A; McGlave PB; Wagner JE; Weisdorf DJ
    Biol Blood Marrow Transplant; 2008 Mar; 14(3):282-9. PubMed ID: 18275894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative outcomes between cord blood transplantation and bone marrow or peripheral blood stem cell transplantation from unrelated donors in patients with hematologic malignancies: a single-institute analysis.
    Chen YH; Xu LP; Liu DH; Chen H; Zhang XH; Han W; Wang FR; Wang JZ; Wang Y; Huang XJ; Liu KY
    Chin Med J (Engl); 2013 Jul; 126(13):2499-503. PubMed ID: 23823825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haplo-cord transplantation using CD34+ cells from a third-party donor to speed engraftment in high-risk patients with hematologic disorders.
    Kwon M; Bautista G; Balsalobre P; Sánchez-Ortega I; Serrano D; Anguita J; Buño I; Fores R; Regidor C; García Marco JA; Vilches C; de Pablo R; Fernández MN; Gayoso J; Duarte R; Díez-Martín JL; Cabrera R
    Biol Blood Marrow Transplant; 2014 Dec; 20(12):2015-22. PubMed ID: 25255162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrabone cord blood hematopoietic stem cell transplantation in a subset of very high-risk pediatric patients: a safety and feasibility pilot study.
    Saglio F; Berger M; Vassallo E; Nesi F; Gunetti M; Fazio L; Rustichelli D; Ferrero I; Fagioli F
    J Pediatr Hematol Oncol; 2012 Jul; 34(5):359-63. PubMed ID: 22322938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study.
    Frassoni F; Gualandi F; Podestà M; Raiola AM; Ibatici A; Piaggio G; Sessarego M; Sessarego N; Gobbi M; Sacchi N; Labopin M; Bacigalupo A
    Lancet Oncol; 2008 Sep; 9(9):831-9. PubMed ID: 18693069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment.
    Horwitz ME; Chao NJ; Rizzieri DA; Long GD; Sullivan KM; Gasparetto C; Chute JP; Morris A; McDonald C; Waters-Pick B; Stiff P; Wease S; Peled A; Snyder D; Cohen EG; Shoham H; Landau E; Friend E; Peleg I; Aschengrau D; Yackoubov D; Kurtzberg J; Peled T
    J Clin Invest; 2014 Jul; 124(7):3121-8. PubMed ID: 24911148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic graft-versus-host disease (cGVHD) following unrelated donor hematopoietic stem cell transplantation (HSCT): higher response rate in recipients of unrelated donor (URD) umbilical cord blood (UCB).
    Arora M; Nagaraj S; Wagner JE; Barker JN; Brunstein CG; Burns LJ; Defor TE; McMillan ML; Miller JS; Weisdorf DJ
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1145-52. PubMed ID: 17889350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Umbilical cord blood transplantation--how, when and for whom?
    Cohen Y; Nagler A
    Blood Rev; 2004 Sep; 18(3):167-79. PubMed ID: 15183901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hematopoietic stem-cell transplantation using umbilical-cord blood.
    Cohena Y; Nagler A
    Leuk Lymphoma; 2003 Aug; 44(8):1287-99. PubMed ID: 12952221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts.
    Raiola AM; Dominietto A; di Grazia C; Lamparelli T; Gualandi F; Ibatici A; Bregante S; Van Lint MT; Varaldo R; Ghiso A; Gobbi M; Carella AM; Signori A; Galaverna F; Bacigalupo A
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1573-9. PubMed ID: 24910379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery.
    Green MM; Chao N; Chhabra S; Corbet K; Gasparetto C; Horwitz A; Li Z; Venkata JK; Long G; Mims A; Rizzieri D; Sarantopoulos S; Stuart R; Sung AD; Sullivan KM; Costa L; Horwitz M; Kang Y
    J Hematol Oncol; 2016 Aug; 9(1):71. PubMed ID: 27535663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiRNAs and piRNAs from bone marrow mesenchymal stem cell extracellular vesicles induce cell survival and inhibit cell differentiation of cord blood hematopoietic stem cells: a new insight in transplantation.
    De Luca L; Trino S; Laurenzana I; Simeon V; Calice G; Raimondo S; Podestà M; Santodirocco M; Di Mauro L; La Rocca F; Caivano A; Morano A; Frassoni F; Cilloni D; Del Vecchio L; Musto P
    Oncotarget; 2016 Feb; 7(6):6676-92. PubMed ID: 26760763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Single center comparative analysis of hematopoietic cell transplantation from alternated donor in patients with hematologic malignancies].
    Wang J; Zhou J; Zheng HF; Wang PF; Fu CC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Feb; 23(1):159-65. PubMed ID: 25687066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of engraftment, graft-versus-host disease, and immune recovery following unrelated donor cord blood transplantation.
    Thomson BG; Robertson KA; Gowan D; Heilman D; Broxmeyer HE; Emanuel D; Kotylo P; Brahmi Z; Smith FO
    Blood; 2000 Oct; 96(8):2703-11. PubMed ID: 11023501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy.
    Bensinger WI; Buckner CD; Shannon-Dorcy K; Rowley S; Appelbaum FR; Benyunes M; Clift R; Martin P; Demirer T; Storb R; Lee M; Schiller G
    Blood; 1996 Dec; 88(11):4132-8. PubMed ID: 8943847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strategies to enhance umbilical cord blood stem cell engraftment in adult patients.
    Delaney C; Ratajczak MZ; Laughlin MJ
    Expert Rev Hematol; 2010 Jun; 3(3):273-83. PubMed ID: 20835351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mesenchymal stem cells from human cord blood promote engraftment of human umbilical cord blood-derived CD34+ cells in NOD/SCID mice].
    Zhou DH; Huang SL; Huang K; Wu YF; Bao R; Wei J; Zhang XC; Li Y
    Zhonghua Xue Ye Xue Za Zhi; 2005 Dec; 26(12):732-5. PubMed ID: 16620577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical study of unrelated umbilical cord blood transplantation for 25 patients with hematological diseases].
    Chang HR; Cheng Z; Chen GH; Sun AN; Qiao M; Ma X; Wang Y; Chen F; Jin HY; Lu Y; Zhang JQ; Fu CC; Jin ZM; Tang XW; Han Y; Qiu HY; Wu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):767-73. PubMed ID: 24989292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of graft compositions on hematopoietic reconstitution and graft-versus-host disease in related donor peripheral blood stem cell transplantation].
    Zhan Y; Yi ZS; Wei YQ; Huang F; Zhang YM; Fan ZP; Feng R
    Zhonghua Xue Ye Xue Za Zhi; 2008 May; 29(5):333-6. PubMed ID: 18844073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.